Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6

J Leukoc Biol. 2007 Aug;82(2):354-60. doi: 10.1189/jlb.0207111. Epub 2007 May 15.

Abstract

Cross-talk between TGF-beta and IL-6 has been shown to direct the differentiation of CD4(+) cells into special IL-17-secreting cells, which are termed Th17 cells. In this study, we demonstrated that TGF-beta and IL-6 could stimulate CD8(+) cells to differentiate into noncytotoxic, IL-17-producing cells in MLC. These IL-17-producing CD8(+) cells exhibit a unique granzyme B(-)IFN-gamma(-)IL-10(-) phenotype. The mRNA level of Th2/T cytotoxic 2 (Tc2) transcription factors GATA3 and Th1/Tc1 transcription factors T-box expressed in T cell (T-bet) as well as its target H2.O-like homeobox (Hlx) is decreased in CD8(+) cells from TGF-beta- and IL-6-treated MLC. In addition, these CD8(+) cells display a marked up-regulation of retinoic acid-related orphan receptor-gammat, a key IL-17 transcription factor. These results demonstrate that the existence of an IL-17-producing CD8(+) subset belongs to neither the Tc1 nor the Tc2 subset and can be categorized as a T noncytotoxic 17 (Tnc17) subset.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD8 Antigens / analysis*
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Line, Tumor
  • Cells, Cultured
  • Female
  • Interleukin-17 / metabolism
  • Interleukin-6 / immunology
  • Interleukin-6 / pharmacology*
  • Lymphocyte Culture Test, Mixed
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • RNA, Messenger / metabolism
  • T-Lymphocytes, Cytotoxic / immunology
  • Th1 Cells / immunology
  • Transforming Growth Factor beta / pharmacology*

Substances

  • CD8 Antigens
  • Interleukin-17
  • Interleukin-6
  • RNA, Messenger
  • Transforming Growth Factor beta